A new guideline published in Clinical & Experimental Allergy will help clinicians evaluate and test patients for potential penicillin allergies.
The guideline was developed by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI) along with a committee of experts and key stakeholders.
The group's recommendations include a checklist to identify patients at low risk of allergy and a framework for conducting drug provocation testing—or exposure to penicillin in a controlled environment—by non-allergists. There are separate recommendations for adults and children within the guideline.
"The intended users are non-allergists with an interest in clarifying the penicillin allergy status of their patients. The guideline details appropriate patient selection, risk stratification, minimum safety standards, conduct of a drug provocation test, and the degree of oversight required from allergy or immunology specialists," the authors wrote. "The guideline will be reviewed 5 years from original publication date."
URL Upon Publication: https://onlinelibrary.wiley.com/doi/10.1111/cea.14217
Additional Information
